These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9655201)

  • 21. Intratympanic gentamicin instillation as treatment of unilateral Menière's disease: update of an ongoing study.
    Nedzelski JM; Chiong CM; Fradet G; Schessel DA; Bryce GE; Pfleiderer AG
    Am J Otol; 1993 May; 14(3):278-82. PubMed ID: 8372926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The long-term results of treatment of Ménière's disease with intratympanic injections of gentamicin].
    Gawęcki W; Szyfter W; Lączkowska-Przybylska J; Szyfter-Harris J
    Otolaryngol Pol; 2012; 66(1):20-6. PubMed ID: 22381010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA; Chen DA; Arriaga MA
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF; Poe DS
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intratympanic gentamicin therapy for persistent vertigo after endolymphatic sac surgery.
    Marzo SJ; Leonetti JP
    Otolaryngol Head Neck Surg; 2002 Jan; 126(1):31-3. PubMed ID: 11821762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Small doses of gentamicin drum indoor injection treatment of intractableMénière disease clinical observation of the impact of the hearing].
    Wang XY
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 30(12):942-944. PubMed ID: 29771059
    [No Abstract]   [Full Text] [Related]  

  • 28. Low-dose intratympanic gentamicin treatment of Menière's disease.
    Inoue H; Uchi Y; Nogami K; Uemura T
    Eur Arch Otorhinolaryngol; 1994; 251 Suppl 1():S12-4. PubMed ID: 11894767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angular vestibulo-ocular reflex gains correlate with vertigo control after intratympanic gentamicin treatment for Meniere's disease.
    Lin FR; Migliaccio AA; Haslwanter T; Minor LB; Carey JP
    Ann Otol Rhinol Laryngol; 2005 Oct; 114(10):777-85. PubMed ID: 16285268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low dose transtympanic gentamicin treatment for intractable Meniere's disease: a prospective study.
    Kasemsuwan L; Jariengprasert C; Ruencharopen S; Orathai P
    J Med Assoc Thai; 2007 Feb; 90(2):327-34. PubMed ID: 17375639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere's disease.
    Öztürk K; Ata N
    Am J Otolaryngol; 2019; 40(5):711-714. PubMed ID: 31262549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
    Kyrodimos E; Aidonis I; Sismanis A
    J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
    Quaranta A; Aloisi A; De Benedittis G; Scaringi A
    Ann N Y Acad Sci; 1999 Nov; 884():410-24. PubMed ID: 10842610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy of intratympanic gentamicin and dexamethasone in the treatment of intractable Meniere's disease].
    Wang QL; Guo XD; Mei XS; Li Y; Yao WJ; Yang XG
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):96-99. PubMed ID: 29871195
    [No Abstract]   [Full Text] [Related]  

  • 35. Intratympanic gentamicin in monolateral Meniere's disease: our experience.
    Bertino G; Durso D; Manfrin M; Casati L; Mira E
    Eur Arch Otorhinolaryngol; 2006 Mar; 263(3):271-5. PubMed ID: 16021460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial.
    Patel M; Agarwal K; Arshad Q; Hariri M; Rea P; Seemungal BM; Golding JF; Harcourt JP; Bronstein AM
    Lancet; 2016 Dec; 388(10061):2753-2762. PubMed ID: 27865535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postural compensation after intratympanic gentamicin treatment of Menière's disease.
    Pyykkö I; Eklund S; Ishizaki H; Aalto H
    J Vestib Res; 1999; 9(1):19-26. PubMed ID: 10334013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of increased gentamicin concentration for intratympanic injection therapy in Ménière's disease.
    Abou-Halawa AS; Poe DS
    Otol Neurotol; 2002 Jul; 23(4):494-502; discussion 502-3. PubMed ID: 12170152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intratympanic gentamicin for treatment of intractable Meniere's disease: a preliminary report.
    Rauch SD; Oas JG
    Laryngoscope; 1997 Jan; 107(1):49-55. PubMed ID: 9001265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term results after interval therapy with intratympanic gentamicin for Menière's disease.
    Lange G; Maurer J; Mann W
    Laryngoscope; 2004 Jan; 114(1):102-5. PubMed ID: 14710003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.